NO20010715D0 - Fenylyantinderivater - Google Patents

Fenylyantinderivater

Info

Publication number
NO20010715D0
NO20010715D0 NO20010715A NO20010715A NO20010715D0 NO 20010715 D0 NO20010715 D0 NO 20010715D0 NO 20010715 A NO20010715 A NO 20010715A NO 20010715 A NO20010715 A NO 20010715A NO 20010715 D0 NO20010715 D0 NO 20010715D0
Authority
NO
Norway
Prior art keywords
fenylyantinderivater
Prior art date
Application number
NO20010715A
Other languages
English (en)
Other versions
NO20010715L (no
Inventor
Susan Mary Daluge
Cynthia Holder Jurgensen
Michael Tolar Martin
Martin Howard Ostehout
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20010715D0 publication Critical patent/NO20010715D0/no
Publication of NO20010715L publication Critical patent/NO20010715L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20010715A 1998-08-13 2001-02-12 Fenylyantinderivater NO20010715L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9817623.3A GB9817623D0 (en) 1998-08-13 1998-08-13 Pharmaceutical compounds
PCT/EP1999/005814 WO2000009507A1 (en) 1998-08-13 1999-08-11 Phenyl yanthine derivatives

Publications (2)

Publication Number Publication Date
NO20010715D0 true NO20010715D0 (no) 2001-02-12
NO20010715L NO20010715L (no) 2001-04-02

Family

ID=10837179

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010715A NO20010715L (no) 1998-08-13 2001-02-12 Fenylyantinderivater

Country Status (37)

Country Link
US (3) US6608069B1 (no)
EP (1) EP1104422B1 (no)
JP (3) JP3631961B2 (no)
KR (1) KR20010085369A (no)
CN (2) CN1251676C (no)
AP (1) AP1408A (no)
AR (1) AR020154A1 (no)
AT (1) ATE259810T1 (no)
AU (1) AU775819B2 (no)
BR (1) BR9913020A (no)
CA (1) CA2340350A1 (no)
CO (1) CO5130007A1 (no)
DE (1) DE69914921T2 (no)
DK (1) DK1104422T3 (no)
EA (1) EA004139B1 (no)
EE (1) EE04721B1 (no)
ES (1) ES2215399T3 (no)
GB (1) GB9817623D0 (no)
HK (1) HK1035195A1 (no)
HU (1) HUP0103637A3 (no)
ID (1) ID28723A (no)
IL (1) IL141318A0 (no)
IS (1) IS5843A (no)
MA (1) MA26673A1 (no)
MY (1) MY133393A (no)
NO (1) NO20010715L (no)
NZ (1) NZ509778A (no)
PE (1) PE20000952A1 (no)
PL (1) PL346055A1 (no)
PT (1) PT1104422E (no)
SI (1) SI1104422T1 (no)
SK (1) SK2222001A3 (no)
TR (1) TR200100448T2 (no)
TW (1) TWI224598B (no)
WO (1) WO2000009507A1 (no)
YU (1) YU11601A (no)
ZA (1) ZA200101186B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9703044D0 (en) 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
AU2002248910A1 (en) * 2000-11-17 2002-05-27 Idenix (Cayman) Limited Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrmidines
AU2002252134A1 (en) * 2001-02-28 2002-09-12 Smithkline Beecham Corporation Methods of treating irritable bowel syndrome and functional dyspepsia
WO2003017964A1 (en) 2001-08-24 2003-03-06 Unilever N.V. Oral composition comprising an alkylhydroxybenzoate
US7317017B2 (en) 2002-11-08 2008-01-08 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
DK1444233T3 (da) 2001-11-09 2011-10-17 Gilead Palo Alto Inc A2B-adenosinreceptorantagonister
US7125993B2 (en) 2001-11-09 2006-10-24 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US6977300B2 (en) 2001-11-09 2005-12-20 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US20040072848A1 (en) * 2002-02-26 2004-04-15 Huber Brian E Methods of treating irritable bowel syndrome and functional dyspepsia
EP1521584A1 (en) 2002-06-17 2005-04-13 Glaxo Group Limited Purine derivatives as liver x receptor agonists
WO2005021548A2 (en) * 2003-08-25 2005-03-10 Adenosine Therapeutics, Llc Substituted 8-heteroaryl xanthines
GB0324086D0 (en) * 2003-10-14 2003-11-19 Glaxo Group Ltd Process for preparing a co-precipitate of a non-crystalline solid drug substance
WO2006004903A2 (en) * 2004-06-28 2006-01-12 Atherogenics, Inc. 1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
WO2006091898A2 (en) * 2005-02-25 2006-08-31 Adenosine Therapeutics, Llc Pyrazolyl substituted xanthines
US7598379B2 (en) 2005-02-25 2009-10-06 Pgx Health, Llc Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines
US7884100B2 (en) * 2006-06-16 2011-02-08 Pgxhealth, Llc Substituted 8-[6-amino-3-pyridyl]xanthines
WO2009140517A1 (en) 2008-05-14 2009-11-19 Hydra Biosciences, Inc. Compounds and compositions for treating chemical warfare agent-induced injuries
WO2010039289A2 (en) 2008-05-14 2010-04-08 Hydra Biosciences, Inc. Compounds and compositions for treating chemical warfare agent-induced injuries
US20120108614A1 (en) * 2008-05-14 2012-05-03 Chong Jayhong A Compounds and compositions for treating chemical warfare agent-induced injuries
CN102105474B (zh) * 2008-05-30 2014-01-08 健泰科生物技术公司 嘌呤pi3k抑制剂化合物及使用方法
CN102260260B (zh) * 2010-05-24 2014-08-06 中国科学院上海药物研究所 8-苯基黄嘌呤类化合物、其制备方法、包含该化合物的药物组合物及其用途
CN102993203B (zh) * 2011-09-09 2015-11-25 温州医学院 8-苯基黄嘌呤类衍生物的制备及应用
US9502952B2 (en) 2012-10-12 2016-11-22 Persimmon Technologies, Corp. Hybrid motor
CA2911818A1 (en) * 2013-05-10 2014-11-13 Nimbus Apollo, Inc. Acc inhibitors and uses thereof
CA2911932A1 (en) 2013-05-10 2014-11-13 Nimbus Apollo, Inc. Acc inhibitors and uses thereof
MX2015015417A (es) * 2013-05-10 2016-06-21 Nimbus Apollo Inc Inhibidores de acetil-coa carboxilasa (acc) y usos de los mismos.
WO2014182951A1 (en) 2013-05-10 2014-11-13 Nimbus Apollo, Inc. Acc inhibitors and uses thereof
WO2024133605A1 (en) 2022-12-20 2024-06-27 Invios Gmbh Substituted 3,7-dihydro-1 h-purine-2,6-diones and use thereof
EP4389749A1 (en) * 2022-12-20 2024-06-26 invIOs GmbH Substituted 3,7-dihydro-1h-purine-2,6-diones and use thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442125A (en) * 1978-06-26 1984-04-10 Oxford Hill, Ltd. Process for detaching or preventing attachment of microorganisms to a surface
GB8510758D0 (en) 1985-04-27 1985-06-05 Wellcome Found Compounds
US4968672A (en) * 1987-01-02 1990-11-06 The United States Of America As Represented By The Department Of Health And Human Services Adenosine receptor prodrugs
US5015647A (en) 1987-04-24 1991-05-14 Burroughs Wellcome Co. Method for treating viral infections
GB8826595D0 (en) 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
GB8906792D0 (en) 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
IL100088A (en) 1990-11-21 1995-07-31 Smithkline Beecham Corp FNT inhibitor preparations containing histogenic transducts converted at positions 1, 3, and 8
GB9210839D0 (en) 1992-05-21 1992-07-08 Smithkline Beecham Plc Novel compounds
TW252044B (no) 1992-08-10 1995-07-21 Boehringer Ingelheim Kg
JP2613355B2 (ja) 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
WO1995013094A1 (en) * 1993-11-10 1995-05-18 Bristol-Myers Squibb Company Treatment of bacterially-induced inflammatory diseases
US5395831A (en) 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
GB9415529D0 (en) * 1994-08-01 1994-09-21 Wellcome Found Phenyl xanthine derivatives
DE19535504A1 (de) 1995-09-25 1997-03-27 Bayer Ag Substituierte Xanthine
AU2213697A (en) 1996-03-18 1997-10-10 Medical Science Systems, Inc. A method for periodontal disease treatment
PT812844E (pt) 1996-06-07 2003-03-31 Hoechst Ag Utilizacao de derivados de teofilina para o tratamento e profilaxia de estados de choque novos compostos de xantina e processo para a sua preparacao
GB9703044D0 (en) * 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
US6096707A (en) * 1997-07-11 2000-08-01 Biotie Therapies Ltd. Integrin binding peptide and use thereof
US6117878A (en) * 1998-02-24 2000-09-12 University Of Virginia 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
WO1999043673A1 (fr) 1998-02-26 1999-09-02 Zenyaku Kogyo Kabushiki Kaisha Derives de 1-aza-indolizine
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
IL150368A0 (en) 1999-12-23 2002-12-01 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2-inhibitors, compositions and methods of use
US20020006915A1 (en) * 2000-02-15 2002-01-17 Mack Strong Vivian E. Use of COX-2 inhibitors to treat sepsis, complications thereof, and EP receptor modulation
US6751206B1 (en) 2000-06-29 2004-06-15 Qualcomm Incorporated Method and apparatus for beam switching in a wireless communication system

Also Published As

Publication number Publication date
CA2340350A1 (en) 2000-02-24
KR20010085369A (ko) 2001-09-07
HK1035195A1 (en) 2001-11-16
ATE259810T1 (de) 2004-03-15
EE04721B1 (et) 2006-10-16
SK2222001A3 (en) 2001-12-03
AP2001002071A0 (en) 2001-03-31
DE69914921D1 (en) 2004-03-25
JP3631961B2 (ja) 2005-03-23
TR200100448T2 (tr) 2001-09-21
US20030032804A1 (en) 2003-02-13
IL141318A0 (en) 2002-03-10
NO20010715L (no) 2001-04-02
ES2215399T3 (es) 2004-10-01
MA26673A1 (fr) 2004-12-20
HUP0103637A3 (en) 2002-10-28
EA200100127A1 (ru) 2001-10-22
DK1104422T3 (da) 2004-06-14
US20040034020A1 (en) 2004-02-19
HUP0103637A2 (en) 2002-06-29
SI1104422T1 (en) 2004-06-30
CN1515571A (zh) 2004-07-28
US6608069B1 (en) 2003-08-19
YU11601A (sh) 2004-03-12
TWI224598B (en) 2004-12-01
JP2004115534A (ja) 2004-04-15
NZ509778A (en) 2003-08-29
US6770267B2 (en) 2004-08-03
PL346055A1 (en) 2002-01-14
IS5843A (is) 2001-02-09
BR9913020A (pt) 2001-05-08
PE20000952A1 (es) 2000-09-29
WO2000009507A1 (en) 2000-02-24
AP1408A (en) 2005-05-06
ID28723A (id) 2001-06-28
EP1104422A1 (en) 2001-06-06
JP2002522542A (ja) 2002-07-23
CN1251676C (zh) 2006-04-19
CO5130007A1 (es) 2002-02-27
CN1323309A (zh) 2001-11-21
GB9817623D0 (en) 1998-10-07
ZA200101186B (en) 2002-02-12
JP2004137251A (ja) 2004-05-13
EP1104422B1 (en) 2004-02-18
AR020154A1 (es) 2002-04-10
EA004139B1 (ru) 2004-02-26
AU5732399A (en) 2000-03-06
AU775819B2 (en) 2004-08-19
DE69914921T2 (de) 2004-12-23
CN1149215C (zh) 2004-05-12
PT1104422E (pt) 2004-06-30
MY133393A (en) 2007-11-30
EE200100083A (et) 2002-06-17

Similar Documents

Publication Publication Date Title
DE69924816D1 (de) Fluidumverdichter
NO20012596D0 (no) Röranker
ID23211A (id) Sulfanilsilana
DE69908817D1 (de) Laderaum
NO20005960L (no) Differensialinjektor
FI980536A0 (fi) Monteringslinje
NO20010715D0 (no) Fenylyantinderivater
DE69928148D1 (de) Wasserskimmer
NO994559L (no) Löftemotor
DE59906931D1 (de) Exzenterzahnradgetriebe
NO20006688D0 (no) Brönner
DE69940418D1 (de) Tonsignalsmischung
DE69919644D1 (de) Wellenabstreifdichtung
DE69938476D1 (de) Münzschiebespielgerät
IT1312305B1 (it) Trisresorciniltriazine
NO20012446D0 (no) Sviveltetning
DE69938807D1 (de) Eindrücksteckverbinder
DE69905102D1 (de) Spritzgiessmaschinensteuerung
FI980821A0 (fi) Nabb foer fordonsdaeck
DE59910289D1 (de) Friktionsdrallvorrichtung
DE69927870D1 (de) Andruckkontaktanschlussklemme
ATA126298A (de) Verpuffungsklappe
DE69901909D1 (de) Kinevideokamera
FI980319A0 (fi) Reglersystem foer en flerskiktsinloppslaoda
EE200100028A (et) Glisser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application